News

Finding those most at risk of falls

19 August 2014

A new study from MS Research Australia-supported researchers Dr Phu Hoang and Professor Stephen Lord, along with international research groups from Sweden, the UK, and the USA, are joining forces to bring together the most comprehensive analysis of falls data in MS.

By combining the findings from separate research groups, the researchers assessed falls risk across a wide range of ages and disease severity levels, allowing them to determine which illness-related and demographic factors may most strongly influence the risk of falling.

They combined data from 537 individuals who had reported 1,721 falls during the study period. The findings describe a range of characteristics that were associated with the falls: most falls occurred inside, between key daytime hours (6am-6pm). They also found that the risk of falls was lower in women than in men.

Importantly, they identified that the risk of falls actually declined with age, and also was not directly associated with the level of illness-related disability. This suggests that MS severity may not be specifically predictive of a person’s risk of falling, and highlights the importance of taking care and using a walking aid where necessary. The authors suggest that the younger age group may be related to a higher falls risk as the older people typically use more caution and avoid potentially risky activity.

If you feel you may need assistance with mobility or may be at risk of falling, please contact your state MS society for more information.

Related News

Media Release

Early results show world-first adaptive trial in action for progressive MS

17 September 2026

A potential treatment for progressive multiple sclerosis (MS) will continue in a world-first multi-arm, multi-stage adaptive trial after showing encouraging early signs, with recruitment set to expand across Australia.

MS News

Alpha lipoic acid shows promise in Stage 1 of Octopus trial in progressive MS

17 September 2026

Results from Stage 1 of the Octopus trial find one of the trial treatments, alpha lipoic acid, shows promise in progressive MS and will continue into trial Stage 2.

MS News

Women and MS: one of the disease’s biggest mysteries

9 September 2026

Why does MS affect women more often than men? How does female biology impact MS activity? Discover what recent research is revealing about risk, hormones, immunity and EBV.

Read More
DNA genetics

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Finding those most at risk of falls